| publication name | Valvular papillary fibroelastomas Surgical approach |
|---|---|
| Authors | Ehab Mohammed Kasem (1.2) Sheeren Khaled (2.3) |
| year | 2021 |
| keywords | Papillary fibroelastoma, minimally invasive cardiac surgery, cardiac tumors |
| journal | Zagazig University Medical Journal |
| volume | Not Available |
| issue | Not Available |
| pages | Not Available |
| publisher | Not Available |
| Local/International | Local |
| Paper Link | Not Available |
| Full paper | download |
| Supplementary materials | Not Available |
Abstract
Objective:Papillary fibroelastoma(PFE) is the second most common benign cardiac tumors. Although very rare but it has unique histopathological structure making it with higher tendency to embolization with fatal systemic or pulmonary complications we present our experience in managing is very rare cardiac tumors. Surgery is the definitive treatment it can be done safely through conventional sternotomy or minimal invasive approach Methods :From 2008 TO 2020, 7 Patients have been operated for of valvular papillary fibroelastoma All are managed surgical base .4 aortic and 3 mitral cases. Surgical approach according to surgeon preference Results:All patients treated surgical with excision of the mass, neurological cerebral vascular accident are the main complications. one case requires Aortic valve replacement. Other mitral cases need ring annuloplasty for associated sever Mitral regurgitation. No mortality. Estimated ICU stay 30±7 hrs. and inpatient hospital stay 5± 1.5 days. Conclusions: papillary fibroelastoma(PFE) although benign but has fatal outcome secondary to higher tendency to embolize. High clinical suspicious should be raised correlated with diagnostic tool TTE. Surgery is the definitive treatment can be done conventionally or minimal invasive approach safely